EU/EEA Member States prepare for next round in annual reporting for verification of measles and rubella elimination
The summary of the the first intercountry meeting, held in Copenhagen on 24-25 March 2015, hosted jointly by WHO/Europe and the European Centre for Disease Prevention and Control (ECDC) to address issues encountered by the national verfication committeees in European Union (EU)/European Economic Area (EEA) Member States.
Epidemiological update: Measles - monitoring European outbreaks, 23 March 2017
From September 2016 to 17 March 2017, Romania has reported 3 799 cases. In 2016, a number of EU/EEA countries reported measles outbreaks and an increase in the number of cases continues to be observed in 2017.
Flu Awareness Week, 22 – 26 October 2018
The Flu Awareness Week is marked across the WHO European Region every year in October. It aims to raise awareness of the importance of vaccination for people’s health and well-being and to increase the uptake of seasonal influenza vaccination of people with underlying risk factors.
ECDC to implement key council recommendations on vaccination
In a Council Recommendation adopted by EU health ministers today, ECDC has been called on to implement a number of key actions in the fight against vaccine-preventable diseases.
Influenza vaccination coverage rates insufficient across EU Member States
None of the European Union (EU) Member States could demonstrate that they reach the EU target of 75% influenza vaccination coverage for vulnerable groups, according to a new report from the European Centre for Disease Prevention and Control (ECDC).
First COVID-19 vaccine authorised for use in the European Union
ECDC welcomes the authorisation of the first vaccine against COVID-19 in EU/EEA. We have been looking forward to this moment for a long time.
On 21 December, EMA recommended granting a conditional marketing authorisation for the vaccine Comirnaty, developed by BioNTech and Pfizer, to prevent coronavirus disease 2019 (COVID-19) in people from 16 years of age. On the same day, the European Commission has granted market authorisation for EU-wide use.
ECDC releases COVID-19 vaccination rollout strategies for EU/EEA
On 22 December ECDC released the technical report titled ‘COVID-19 vaccination and prioritisation strategies in the EU/EEA’, following the European Medicines Agency (EMA) recommendation for authorisation of the vaccine Comirnaty, developed by BioNTech and Pfizer.